Showing the latest 10 filings. Sign in to filter or browse the full history. View full history
Showing 10 of 74 filings.
14 Oct 2026 2 filings
No brief for this announcement. Newspaper publications aren’t summarised. View the original using the link below
No brief for this announcement. Newspaper publications aren’t summarised. View the original using the link below
9 Oct 2026 1 filing
No brief for this announcement. This type of announcement aren’t summarised. View the original using the link below
1 Oct 2026 2 filings
No brief for this announcement. Newspaper publications aren’t summarised. View the original using the link below
No brief for this announcement. Newspaper publications aren’t summarised. View the original using the link below
30 Sept 2026 1 filing
AGM details
AGM held on 28-09-2026 via VC/OAVM.
Start time: 11:00 AM; end: 11:39 AM.
Record date: 21-09-2026.
Mode: VC/OAVM.
Key resolutions
Resolution 1 (Ordinary): Adoption of audited standalone and consolidated financial statements for FY 2025-26.
Resolution 2 (Ordinary): Declaration of dividend for FY 2025-26.
Resolution 3 (Ordinary): Re-appointment of Mahendra Sanghvi as Director (retire by rotation).
Resolution 4 (Ordinary): Ratification of remuneration payable to Cost Auditors for FY 2026-27.
Resolution 5 (Ordinary): Change in remuneration of Kinjal Bhavsar, MD of Shaily Innovations Ltd UK.
Resolution 6 (Special): Re-appointment of Amit Mahendra Sanghvi as MD for five years from Oct 1, 2026.
Resolution 7 (Special): Enabling resolution to raise funds up to Rs 500 crore via securities.
Voting outcomes
Resolution 1: Passed with no votes against.
Resolution 2: Passed with no votes against.
Resolution 3: Passed; 2.40% against.
Resolution 4: Passed with no votes against.
Resolution 5: Passed; 8.09% against.
Resolution 6: Passed; 6.79% against.
Resolution 7: Passed; 0% against.
All resolutions passed with requisite majorities.
Dividend
Dividend declared for FY2025-26; per-share amount not disclosed.
Director changes
Re-appointment of Mahendra Sanghvi as Director (retiring by rotation).
Amit Mahendra Sanghvi re-appointed as Managing Director from 1 Oct 2026 for five years.
Auditors
Cost Auditor remuneration ratified for FY2026-27.
Fundraising approvals
Enabling resolution to raise funds up to Rs 500 crore via securities approved.
Related party transactions
No material related party transactions disclosed.
28 Sept 2026 2 filings
AGM details
AGM held on 28 September 2026 at 11:00 am IST via VC/OAVM.
Resolutions put to vote
Ordinary: Adoption of standalone and consolidated financial statements for year ended 31 March 2026.
Ordinary: Dividend on equity shares for FY2025-26.
Ordinary: Re-appointment of Mahendra Sanghvi, retiring by rotation.
Special: Ratification of remuneration payable to Cost Auditors for FY2026-27.
Special: Change in remuneration of Kinjal Bhavsar, MD of Shaily Innovations UK, effective 1 Apr 2026.
Special: Re-appointment of Amit Mahendra Sanghvi as MD from 1 Oct 2026 for five years.
Special: Enabling resolution to raise funds up to ₹500 crore via securities.
Voting results
Resolution outcomes not disclosed; results to be announced on company website and stock exchanges.
Adoption of financial statements: outcome not disclosed.
Dividend: outcome not disclosed.
Director rotation: outcome not disclosed.
Cost Auditors remuneration: outcome not disclosed.
UK MD remuneration: outcome not disclosed.
MD re-appointment: outcome not disclosed.
Fund-raise authority: outcome not disclosed.
Auditors
Remuneration for Cost Auditors ratified for FY2026-27.
AGM Details
AGM held 28 September 2026 at 11:00 a.m. IST via VC/OAVM.
Ordinary Business
Adopt standalone and consolidated financial statements for FY2025-26.
Dividend on equity shares for FY2025-26 to be declared.
To appoint a Director in place of Mahendra Sanghvi, retiring by rotation.
Voting results not disclosed in the proceedings.
Special Business
Remuneration payable to Cost Auditors for FY2026-27 to be ratified.
Change in remuneration of Kinjal Bhavsar, MD, Shaily Innovations UK, effective 1 Apr 2026.
Re-appointment of Amit Mahendra Sanghvi as MD for five years from 1 Oct 2026.
Enabling resolution to raise up to ₹500 crore through securities.
26 Sept 2026 2 filings
Ratings & Action
Long-term bank facilities Rs239.24 crore; CARE A+; Stable; rating reaffirmed.
Short-term bank facilities Rs35.00 crore; CARE A1+; upgraded from CARE A1.
Term Loans
HDFC Bank Rs38.42 crore; 18 quarterly installments starting Feb 2025.
SBI Rs1.20 crore; sanctioned Rs8 crore; 20 quarterly installments through Dec 2026.
SBI Rs0.62 crore; moratorium 12 months; 48 monthly installments Oct 2022–Sept 2026.
Fund-based Limits
Total fund-based limits Rs199.00 crore; banks: SBI, HDFC, Standard Chartered; proposed Rs19 crore.
Non-fund Based Limits
Total non-fund-based limits Rs35.00 crore; SBI LC/BG; HDFC LC/BG.
Total Facilities
Total facilities: Rs274.24 crore.
Material Change
Long-term rating reaffirmed; short-term upgraded; facility amount reduced from Rs239.62cr to Rs239.24cr.
Outlook & Agency
Long-term outlook: Stable.
Agency: CARE Ratings Ltd.
Rating Action Details
Long-term bank facilities: Rs.239.24 crore; CARE A+; Stable; Reaffirmed
Short-term bank facilities: Rs.35.00 crore; CARE A1+; Upgraded from A1
Rating agency: CARE Ratings Limited (CARE)
Outlook: Long-term Stable
Material change: Short-term rating upgraded to A1+ from A1
Rationale: Based on FY26 (audited) and Q1FY27 (unaudited) performance